Reports

Changes in immigration regulations have been abundant recently. Magdalena Świtajska and Katarzyna Sawicka write about those that have already come into effect.

Ransomware and data breaches are one of the number one types of threats to cybersecurity. New cybersecurity regulations, such as the DORA Act and the NIS2 Directive, recognize this and require businesses to implement incident management procedures. Our guide is the culmination of nearly 10 years of experience in managing ransomware and data breach incidents and provides a comprehensive framework...

On 19 May 2024, Directive 2024/1226 enters into force, which is expected to bring a more unified and more effective approach to sanctions enforcement in the EU. This means that all business operators should step up their sanctions compliance efforts. Lukasz Lasek and Anna Olejniczak-Michalska write about the details.

ESG and sustainability are a new field for many entities. To help businesses navigate through the maze of regulations, we have identified the main issues from different areas of law where ESG and sustainability risks may arise. We also suggest ways to help mitigate these risks.

Our team has recently conducted a range of corporate reorganisations, including mergers (some cross-border), conversions and demergers (including demerger by spin-off). This experience has encouraged us to gather our knowhow in one place and discuss issues that are useful in practice.

What legal traps can a developer fall into when creating a game? Find out by playing the role of Creative, Manager, Accountant or Consultant in the Gamedev CEO simulator game created by the Gaming practice at Wardyński & Partners.

Joanna Krakowiak and Marcin Rytel examine the planned reform of EU pharmaceutical law—the biggest in 20 years. How will the new regulations affect innovation and access to affordable medicines? Will they reduce the environmental impact of pharmaceutical production?

The new edition of the annual publication Investing in Healthcare & Life Sciences has now been released. At the invitation of McDermott Will & Emery, publishers of the guide, Joanna Krakowiak drafted the chapter on the regulatory environment for the healthcare sector in Poland.

How to conduct clinical trials in Poland - in questions and aswers.

The 20th edition of the International Comparative Legal Guide to pharmaceutical advertising has now been published. Experts from our firm wrote the chapter on Poland.